Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
A Double-blind, Multi-center, Multi-regional, Randomized controlled, Phase 3 Clinical Trial
to Evaluate the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed with
COVID-19